Usana Health Sciences (USNA) Cost of Revenue (2010 - 2026)

Usana Health Sciences (USNA) has 17 years of Cost of Revenue data on file, last reported at $59.4 million in Q2 2026.

• Cost of Revenue for Q2 2026 came in at $59.4 million, up 13.33% year-over-year; the trailing twelve-month figure through Apr 2026 was $207.8 million (up 21.84% YoY), and the FY2026 annual result was $200.9 million, up 24.59% from the prior year.
• Cost of Revenue improved to $59.4 million in Q2 2026 per USNA's latest filing, from $49.4 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $67.8 million in Q1 2022 and troughed at $38.6 million in Q4 2024.
• A 5-year average of $47.8 million and a median of $47.5 million in 2022 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2022 and 2026: Cost of Revenue slumped 31.53% in 2022, then gained 28.16% in 2026.
• A 5-year view of Cost of Revenue shows it stood at $46.4 million in 2022, then dropped by 8.85% to $42.3 million in 2023, then fell by 8.9% to $38.6 million in 2024, then increased by 26.62% to $48.8 million in 2025, then climbed by 21.76% to $59.4 million in 2026.
• Business Quant data shows USNA's Cost of Revenue at $59.4 million in Q2 2026, $49.4 million in Q1 2026, and $48.8 million in Q3 2025.